Legacy Private Trust Co. Bristol Myers Squibb CO Transaction History

Legacy Private Trust Co.

$1.39 Billion
Q2 2024

A detailed history of Legacy Private Trust Co. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Legacy Private Trust Co. holds 11,034 shares of BMY stock, worth $571,009. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,034

Previous 11,679 5.52%

Holding current value

$571,009

Previous $633,000 27.65%

% of portfolio

0.03%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$40.25 - $52.99 $25,961 - $34,178	-645 Reduced 5.52%	11,034 $458,000
Q1 2024 Apr 10, 2024	BUY	$47.98 - $54.4 $19,192 - $21,760	400 Added 3.55%	11,679 $633,000
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $43,874 - $52,354	-905 Reduced 7.43%	11,279 $578,000
Q3 2023 Oct 11, 2023	SELL	$57.89 - $64.73 $9,841 - $11,004	-170 Reduced 1.38%	12,184 $707,000
Q1 2023 Apr 12, 2023	BUY	$65.71 - $74.53 $985 - $1,117	15 Added 0.12%	12,354 $856,000
Q4 2022 Jan 06, 2023	BUY	$68.48 - $81.09 $1,027 - $1,216	15 Added 0.12%	12,339 $888,000
Q3 2022 Oct 06, 2022	SELL	$0.13 - $76.84 $63 - $37,805	-492 Reduced 3.84%	12,324 $876,000
Q1 2022 Apr 11, 2022	SELL	$61.48 - $73.72 $30,617 - $36,712	-498 Reduced 3.74%	12,816 $936,000
Q4 2021 Jan 12, 2022	SELL	$53.63 - $62.52 $82,590 - $96,280	-1,540 Reduced 10.37%	13,314 $830,000
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $24,259 - $28,417	-410 Reduced 2.69%	14,854 $879,000
Q2 2021 Jul 09, 2021	SELL	$61.91 - $67.42 $44,946 - $48,946	-726 Reduced 4.54%	15,264 $1.02 Million
Q1 2021 Apr 09, 2021	SELL	$59.34 - $66.74 $72,572 - $81,623	-1,223 Reduced 7.11%	15,990 $1.01 Million
Q4 2020 Jan 12, 2021	SELL	$57.74 - $65.43 $56,931 - $64,513	-986 Reduced 5.42%	17,213 $1.07 Million
Q3 2020 Oct 14, 2020	SELL	$57.43 - $63.64 $39,396 - $43,657	-686 Reduced 3.63%	18,199 $1.1 Million
Q2 2020 Jul 09, 2020	SELL	$54.82 - $64.09 $174,327 - $203,806	-3,180 Reduced 14.41%	18,885 $1.11 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $363,868 - $528,786	-7,842 Reduced 26.22%	22,065 $1.23 Million
Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $742,086 - $967,985	15,080 Added 101.71%	29,907 $1.92 Million
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $12,061 - $14,300	-282 Reduced 1.87%	14,827 $752,000
Q1 2019 Apr 11, 2019	SELL	$45.12 - $53.8 $41,284 - $49,227	-915 Reduced 5.71%	15,109 $721,000
Q4 2018 Jan 16, 2019	SELL	$48.76 - $63.23 $49,735 - $64,494	-1,020 Reduced 5.98%	16,024 $833,000
Q3 2018 Oct 10, 2018	BUY	$55.19 - $62.25 $10,706 - $12,076	194 Added 1.15%	17,044 $1.06 Million
Q2 2018 Jul 13, 2018	SELL	$50.53 - $62.98 $123,798 - $154,301	-2,450 Reduced 12.69%	16,850 $932,000
Q1 2018 Apr 13, 2018	SELL	$59.92 - $68.98 $48,834 - $56,218	-815 Reduced 4.05%	19,300 $1.22 Million
Q4 2017 Jan 16, 2018	BUY	$59.94 - $65.35 $25,594 - $27,904	427 Added 2.17%	20,115 $1.23 Million
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $1.09 Million - $1.25 Million	19,688	19,688 $1.26 Million

Others Institutions Holding BMY

# of Institutions

2,402

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Private Trust Co., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Private Trust Co. with notifications on news.

Account

Legacy Private Trust Co. Bristol Myers Squibb CO Transaction History